Malignant Neoplasms of Independent (Primary) Multiple Sites Clinical Trial
Official title:
What is the Difference in the Estimation of Prognosis of Advanced Cancer Patients Between Medical Oncologist, Gynecological Oncologists, and Palliative Care Physicians?
| NCT number | NCT03115528 |
| Other study ID # | 2016-0879 |
| Secondary ID | |
| Status | Withdrawn |
| Phase | |
| First received | |
| Last updated | |
| Start date | December 14, 2017 |
| Est. completion date | December 2030 |
| Verified date | May 2019 |
| Source | M.D. Anderson Cancer Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
Objectives:
Primary Objective:
The primary objective is to identify the difference in the estimation of prognosis of
advanced cancer patients between medical oncologists, gynecological oncologists, and
palliative care physicians
| Status | Withdrawn |
| Enrollment | 0 |
| Est. completion date | December 2030 |
| Est. primary completion date | December 2030 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: 1. Medical oncologists or gynecological who referred patients to the palliative care team; Palliative Care physicians to whom the patients were referred; Patients with locally advanced, metastatic, or, not curable cancer. 2. 18 years old or older Exclusion Criteria: N/A |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| M.D. Anderson Cancer Center |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Estimation of Patient Overall Survival by Oncologists and by Palliative Care Physicians per Estimation of Prognosis Questionnaire | The answer to the question #4, "How long do you think this patient will live?" in the questionnaire is the primary endpoint. Denoting the oncologist estimated OS time from the day of palliative care consult to death by TOnc, palliative care physician estimate by TPalliative, and the true OS time by T0, we define the accuracy of the estimation of OS by oncologists and by palliative care physician as ?Onc = TOnc - T0 ?Palliative = TPalliative - T0. And the difference between these two estimates is calculated as ?OS = ?Onc - ?Palliative. Based on the above formulas, ?OS is actually calculated as (TOnc- TPalliative). The true survival time, T0, is cancelled out by the subtraction. |
6 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03168763 -
Effect of Physician Attire on Patients' Preference of Physician
|
N/A | |
| Completed |
NCT02957565 -
Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During an Outpatient Palliative Care Visit
|
N/A | |
| Recruiting |
NCT03093909 -
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
|
Phase 1 | |
| Active, not recruiting |
NCT02911064 -
Expectations Regarding Mobility and Self-Care
|
||
| Withdrawn |
NCT03177681 -
The Effect of Yogurt in Cancer Patient With Moderate Gastrointestinal (GI) Symptoms
|
N/A | |
| Completed |
NCT03043378 -
Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic
|
||
| Active, not recruiting |
NCT03435952 -
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
|
Phase 1 | |
| Completed |
NCT03042884 -
Wearable Exercise Trackers in Cancer Rehabilitation
|
N/A | |
| Completed |
NCT03035448 -
Communication Strategies to Introduce Psychology Services
|
N/A | |
| Withdrawn |
NCT02915172 -
Lenvatinib and Capecitabine in Patients With Advanced Malignancies
|
Phase 1 |